First-Line Trastuzumab Plus Epirubicin and Cyclophosphamide Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Cardiac Safety and Efficacy Data From the Herceptin, Cyclophosphamide, and Epirubicin (HERCULES) Trial
Untch, M., Muscholl, M., Tjulandin, S., Jonat, W., Meerpohl, H.-G., Lichinitser, M., Manikhas, A. G., Coumbos, A., Kreienberg, R., du Bois, A., Harbeck, N., Jackisch, C., Muller, V., Pauschinger, M.,Volume:
28
Langue:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2009.21.9709
Date:
March, 2010
Fichier:
PDF, 267 KB
english, 2010